Sustiva, Stocrin (efavirenz) is a small molecule pharmaceutical. Efavirenz was first approved as Sustiva on 1998-09-17. It is used to treat acquired immunodeficiency syndrome and HIV infections in the USA. It has been approved in Europe to treat HIV infections. It is known to target cytochrome P450 3A4.
|Trade Name||Stocrin, Sustiva|
|Indication||acquired immunodeficiency syndrome, hiv infections|
|Drug Class||Antivirals: non-nucleoside reverse transcriptase inhibitors; benzoxazinone derivatives; Fc fusion protein|